Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Omega Blend supplements typically contain a mixture of omega-3 and sometimes omega-6 and omega-9 fatty acids, most often derived from fish oil, flaxseed oil, or algal oil. The justification for their use in supporting or treating cardiovascular disease is grounded in scientific evidence, though the strength of that evidence varies depending on the specific cardiovascular outcome measured.

Numerous large-scale observational studies and randomized controlled trials have established that omega-3 fatty acids—particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)—can reduce triglyceride levels, lower blood pressure slightly, and have modest antithrombotic and anti-inflammatory effects. Some meta-analyses and clinical guidelines suggest that omega-3 supplementation may modestly reduce the risk of major cardiovascular events, especially in people with existing cardiovascular disease or high triglycerides. The American Heart Association acknowledges that omega-3s from fish or supplements can be beneficial for certain populations.

However, not all studies have shown consistent benefit, especially in primary prevention (in people without established cardiovascular disease). Recent trials such as REDUCE-IT (with high-dose EPA) have shown significant benefits, while others have shown little or no effect. Omega-9 and omega-6 fatty acids, often included in "Omega Blend" products, do not have as much direct evidence supporting cardiovascular benefits as omega-3s.

In summary, the use of Omega Blend for cardiovascular disease is scientifically supported, but the effect size is modest and more robust for some populations than others.

More about Omega Blend
More about Cardiovascular Disease

Other ingredients used for Cardiovascular Disease

Other health conditions supported by Omega Blend

Products containing Omega Blend